• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌细胞通过 Id-1 调节成骨细胞矿化和破骨细胞分化。

Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1.

机构信息

Department of Pathology, The University of Hong Kong, Pokfulam, Hong Kong, China.

出版信息

Br J Cancer. 2010 Jan 19;102(2):332-41. doi: 10.1038/sj.bjc.6605480. Epub 2009 Dec 15.

DOI:10.1038/sj.bjc.6605480
PMID:20010941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2816654/
Abstract

BACKGROUND

Id-1 is overexpressed in and correlated with metastatic potential of prostate cancer. The role of Id-1 in this metastatic process was further analysed.

METHODS

Conditioned media from prostate cancer cells, expressing various levels of Id-1, were used to stimulate pre-osteoclast differentiation and osteoblast mineralisation. Downstream effectors of Id-1 were identified. Expressions of Id-1 and its downstream effectors in prostate cancers were studied using immunohistochemistry in a prostate cancer patient cohort (N=110).

RESULTS

We found that conditioned media from LNCaP prostate cancer cells overexpressing Id-1 had a higher ability to drive osteoclast differentiation and a lower ability to stimulate osteoblast mineralisation than control, whereas conditioned media from PC3 prostate cancer cells with Id-1 knockdown were less able to stimulate osteoclast differentiation. Id-1 was found to negatively regulate TNF-beta and this correlation was confirmed in human prostate cancer specimens (P=0.03). Furthermore, addition of recombinant TNF-beta to LNCaP Id-1 cell-derived media blocked the effect of Id-1 overexpression on osteoblast mineralisation.

CONCLUSION

In prostate cancer cells, the ability of Id-1 to modulate bone cell differentiation favouring metastatic bone disease is partially mediated by TNF-beta, and Id-1 could be a potential therapeutic target for prostate cancer to bone metastasis.

摘要

背景

Id-1 在前列腺癌的转移潜能中过度表达,并与之相关。进一步分析了 Id-1 在这个转移过程中的作用。

方法

用表达不同水平 Id-1 的前列腺癌细胞的条件培养基来刺激前破骨细胞分化和成骨细胞矿化。鉴定 Id-1 的下游效应物。在前列腺癌患者队列(N=110)中,使用免疫组织化学研究前列腺癌中 Id-1 及其下游效应物的表达。

结果

我们发现,过表达 Id-1 的 LNCaP 前列腺癌细胞的条件培养基具有更高的驱动破骨细胞分化的能力,而刺激成骨细胞矿化的能力较低,而 Id-1 敲低的 PC3 前列腺癌细胞的条件培养基则较难刺激破骨细胞分化。发现 Id-1 负调控 TNF-β,并且在人类前列腺癌标本中证实了这种相关性(P=0.03)。此外,将重组 TNF-β添加到 LNCaP Id-1 细胞衍生的培养基中可阻断 Id-1 过表达对成骨细胞矿化的影响。

结论

在前列腺癌细胞中,Id-1 调节骨细胞分化以促进转移性骨疾病的能力部分由 TNF-β介导,Id-1 可能是前列腺癌向骨转移的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/51b1e3ccd4b6/6605480f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/0b9e380ff625/6605480f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/d8c677b844b2/6605480f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/197c24f22401/6605480f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/577c6da83ec0/6605480f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/238143722518/6605480f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/51b1e3ccd4b6/6605480f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/0b9e380ff625/6605480f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/d8c677b844b2/6605480f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/197c24f22401/6605480f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/577c6da83ec0/6605480f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/238143722518/6605480f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeeb/2816654/51b1e3ccd4b6/6605480f6.jpg

相似文献

1
Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1.前列腺癌细胞通过 Id-1 调节成骨细胞矿化和破骨细胞分化。
Br J Cancer. 2010 Jan 19;102(2):332-41. doi: 10.1038/sj.bjc.6605480. Epub 2009 Dec 15.
2
Protease-activated receptor-2 dependent and independent responses of bone cells to prostate cancer cell secretory products.骨细胞对前列腺癌细胞分泌产物的蛋白酶激活受体-2依赖性和非依赖性反应。
Prostate. 2022 May;82(6):723-739. doi: 10.1002/pros.24316. Epub 2022 Feb 15.
3
Metastatic breast cancer induces an osteoblast inflammatory response.转移性乳腺癌会引发成骨细胞炎症反应。
Exp Cell Res. 2008 Jan 1;314(1):173-83. doi: 10.1016/j.yexcr.2007.09.021. Epub 2007 Oct 4.
4
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.破骨细胞对骨形成的调节涉及Wnt/骨形态发生蛋白信号通路和趋化因子鞘氨醇-1-磷酸。
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20764-9. doi: 10.1073/pnas.0805133106. Epub 2008 Dec 15.
5
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo.NFκB 的药理学抑制作用可减少体外前列腺癌相关破骨细胞生成和体内外溶骨性骨破坏。
Calcif Tissue Int. 2019 Aug;105(2):193-204. doi: 10.1007/s00223-019-00538-9. Epub 2019 Mar 30.
6
TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction.TWIST调节前列腺癌细胞介导的骨细胞活性,并在成骨诱导下上调。
Carcinogenesis. 2008 Aug;29(8):1509-18. doi: 10.1093/carcin/bgn105. Epub 2008 May 2.
7
DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.DU145人前列腺癌细胞表达核因子κB受体激活剂:前列腺癌骨转移过程中的新见解。
Bone. 2007 Apr;40(4):981-90. doi: 10.1016/j.bone.2006.11.006. Epub 2006 Dec 28.
8
Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.吉非替尼抑制间充质干细胞和前列腺癌细胞之间的串扰,导致肿瘤细胞增殖和多西他赛活性抑制。
J Cell Biochem. 2013 May;114(5):1135-44. doi: 10.1002/jcb.24456.
9
Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells.肿瘤坏死因子-α、核因子-κB 和骨形态发生蛋白-2 在调节前列腺癌细胞转移和骨模仿以及 MC3T3-E1 成骨样细胞分化和矿化中的独立和协同作用。
Cancer Sci. 2010 Jan;101(1):103-11. doi: 10.1111/j.1349-7006.2009.01356.x. Epub 2009 Sep 9.
10
Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.前列腺癌细胞通过一种依赖Cbfa1的途径诱导成骨细胞分化。
Cancer Res. 2001 Jul 15;61(14):5652-9.

引用本文的文献

1
GATA3-Driven ceRNA Network in Lung Adenocarcinoma Bone Metastasis Progression and Therapeutic Implications.GATA3驱动的ceRNA网络在肺腺癌骨转移进展中的作用及治疗意义
Cancers (Basel). 2025 Feb 6;17(3):559. doi: 10.3390/cancers17030559.
2
Metastatic prostate cancer-derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein.转移性前列腺癌衍生的细胞外囊泡通过转移 CDCP1 蛋白促进破骨细胞生成。
J Extracell Vesicles. 2023 Mar;12(3):e12312. doi: 10.1002/jev2.12312.
3
RRBP1 depletion of bone metastatic cancer cells contributes to enhanced expression of the osteoblastic phenotype.

本文引用的文献

1
Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis.Dickkopf-1表达在前列腺癌发展早期增加,而在从原发性肿瘤进展至转移的过程中降低。
Prostate. 2008 Sep 15;68(13):1396-404. doi: 10.1002/pros.20805.
2
Cancer statistics, 2008.2008年癌症统计数据。
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.
3
BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype.
骨转移性癌细胞中RRBP1的缺失有助于增强成骨细胞表型的表达。
Front Oncol. 2022 Dec 9;12:1005152. doi: 10.3389/fonc.2022.1005152. eCollection 2022.
4
Effects of Triiodothyronine on Human Osteoblast-Like Cells: Novel Insights From a Global Transcriptome Analysis.三碘甲状腺原氨酸对人成骨样细胞的影响:来自全球转录组分析的新见解
Front Cell Dev Biol. 2022 Jun 17;10:886136. doi: 10.3389/fcell.2022.886136. eCollection 2022.
5
A study of the impact of inhibitors of DNA binding-1 on proliferation and migration in human colon carcinoma cells.DNA 结合蛋白-1 抑制剂对人结肠癌细胞增殖和迁移的影响研究。
Kaohsiung J Med Sci. 2019 Apr;35(4):209-213. doi: 10.1002/kjm2.12037. Epub 2019 Mar 19.
6
A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study.一种使用不同数据集进行综合特征选择的新组合优化方法:一项前列腺癌转录组学研究
PLoS One. 2015 Jun 24;10(6):e0127702. doi: 10.1371/journal.pone.0127702. eCollection 2015.
7
Cavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation.钙网织蛋白 1/穿孔素受体相关因子改变前列腺癌细胞衍生的细胞外囊泡内容物和内化,从而减弱细胞外囊泡介导的破骨细胞生成和成骨细胞增殖。
J Extracell Vesicles. 2014 Jun 25;3. doi: 10.3402/jev.v3.23784. eCollection 2014.
8
Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B.Id1 和 Id3 的表达与前列腺癌分级的增加相关:Id3 优先调节 CDKN1B。
Cancer Med. 2012 Oct;1(2):187-97. doi: 10.1002/cam4.19. Epub 2012 Aug 28.
9
Effect of Id1 knockdown on formation of osteolytic bone lesions by prostate cancer PC3 cells in vivo.Id1基因敲低对前列腺癌PC3细胞在体内形成溶骨性骨病变的影响。
J Huazhong Univ Sci Technolog Med Sci. 2012 Jun;32(3):364-369. doi: 10.1007/s11596-012-0063-1. Epub 2012 Jun 9.
10
Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.Ran 是一种潜在的治疗靶点,适用于那些具有与 PI3K/Akt/mTORC1 和 Ras/MEK/ERK 通路激活相关的分子变化的癌细胞。
Clin Cancer Res. 2012 Jan 15;18(2):380-91. doi: 10.1158/1078-0432.CCR-11-2035. Epub 2011 Nov 16.
前列腺癌中骨形态发生蛋白-6(BMP-6)的过表达与Id-1蛋白增加及侵袭性更强的表型相关。
J Pathol. 2008 Feb;214(3):394-404. doi: 10.1002/path.2292.
4
Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma.Id-1和Id-2是食管鳞状细胞癌转移和预后的标志物。
Br J Cancer. 2007 Nov 19;97(10):1409-15. doi: 10.1038/sj.bjc.6604035. Epub 2007 Nov 13.
5
Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.在小鼠模型中,组织工程骨成为人类乳腺癌转移的靶标。
Cancer Res. 2007 Nov 1;67(21):10304-8. doi: 10.1158/0008-5472.CAN-07-2483.
6
Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells.一种新型分化抑制因子-1(ID-1)结合蛋白小窝蛋白-1的鉴定及其在前列腺癌细胞上皮-间质转化和抗凋亡中的作用
J Biol Chem. 2007 Nov 16;282(46):33284-33294. doi: 10.1074/jbc.M705089200. Epub 2007 Sep 12.
7
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.一种预测前列腺癌根治性前列腺切除术或放疗候选者10年预期寿命的列线图。
J Clin Oncol. 2007 Aug 20;25(24):3576-81. doi: 10.1200/JCO.2006.10.3820.
8
Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer.Id-1表达增加与前列腺癌患者的不良生存显著相关。
Hum Pathol. 2007 Sep;38(9):1321-9. doi: 10.1016/j.humpath.2007.02.011. Epub 2007 Jun 28.
9
Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis.一种新型抗凋亡因子的证据:分化抑制因子或DNA结合蛋白(Id-1)在抗癌药物诱导的细胞凋亡中的作用。
Cancer Sci. 2007 Mar;98(3):308-14. doi: 10.1111/j.1349-7006.2007.00400.x.
10
The multiple roles of Id-1 in cancer progression.Id-1在癌症进展中的多重作用。
Differentiation. 2006 Dec;74(9-10):481-7. doi: 10.1111/j.1432-0436.2006.00083.x.